DEVON, PA — Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE) recently announced two poster presentations at the 18th NFXF International Fragile X Conference, being held July 14-17, 2022, in San Diego, Calif. In addition, Zynerba management will present a company presentation during the conference’s Keynote – Industry Updates session.
Corporate Presentation Details
Title: Zynerba Pharmaceuticals – Development of ZYN002 (Zygel™) for the Treatment of Behavioral Symptoms in Fragile X Syndrome: Partnering to advance the care of children and adolescents with Fragile X Syndrome
Date: Friday, July 15, 2022
Time: 3:15 p.m. – 4:30 p.m. PT (6:15 – 7:30 p.m. ET)
Location: Town and Country – A, Town and Country Resort, San Diego, Calif.
Poster Presentation Details
Title: Long-Term Safety and Sustained Efficacy of ZYN002 Cannabidiol Transdermal Gel
in Children and Adolescents With Fragile X Syndrome (ZYN2-CL-017)
Title: RECONNECT (ZYN2-CL-033): Design of a Phase 3 Trial of ZYN002 Cannabidiol Transdermal Gel in Children and Adolescents With Fragile X Syndrome Based Upon Learnings From CONNECT-FX (ZYN2-CL-016)
Date: Friday, July 15, 2022
Time: 4:30 p.m. – 7:00 p.m. PT (7:30 – 10:30 p.m. ET)
Location: Town and Country Foyer, Town and Country Resort, San Diego, Calif.
Copies of the presentation and posters will be made available on the Zynerba corporate website following the presentations at www.zynerba.com/publications.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and Microsoft Start.